Use of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC7 ion channels

Details for Australian Patent Application No. 2008315952 (hide)

Owner Sanofi-Aventis

Inventors Miehe, Susanne; Struebing, Carsten; Kleemann, Heinz-Werner

Agent Watermark

Pub. Number AU-A-2008315952

PCT Pub. Number WO2009/052972

Priority 07291301.5 26.10.07 EP

Filing date 14 October 2008

Wipo publication date 30 April 2009

International Classifications

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/052972 Priority application(s): WO2009/052972

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008316013-Extraction system for mineral extraction and retaining device for a sensor system therefor

2008315951-Complexes of TRPC domains and SESTD1 domains and methods and uses involving the same